AlzeCure Gets Late-Breaking Abstract on NeuroRestore ACD856 Clinical Data Accepted to AD/PD 2022 Conference

3 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / January 18, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a…

Evotec and Lilly Enter into Drug Discovery Collaboration in Metabolic Diseases

3 years ago

COLLABORATION LEVERAGES EVOTEC'S BROAD METABOLIC EXPERTISE AND UNIQUE KIDNEY DISEASE PATIENT DATABASE AS WELL AS INTEGRATED DATA-DRIVEN DRUG DISCOVERY AND…

MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance

3 years ago

Preliminary 2021 Monjuvi U.S. net product sales of US$ 79.1 million ( € 66.9 million)Anticipated 2022 Monjuvi U.S. net product…

Retrospective Study Finds That Masimo SET® Pulse Oximetry Has No Difference in Accuracy or Bias Between Black People and White People

3 years ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of an abstract presented last Saturday at the Society for Technology…

Empatho Holdings Announces Change of Auditor

3 years ago

Toronto, Ontario--(Newsfile Corp. - January 17, 2022) - Empatho Holdings Inc. (CSE: EMPH) (formerly, Shane Resources Ltd.) ("Empatho" or the…

Restrospective Study Finds That Masimo SET® Pulse Oximetry Has No Difference in Accuracy or Bias Between Black People and White People

3 years ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of an abstract presented last Saturday at the Society for Technology…

Britannia Secures Agreement with RST to Supply UK CBD Market

3 years ago

Remediation Sciences and Technology supplies some of the world's largest CPG and cannabis companies with cannabis extracts RST will provide…

Cloud DX Announces Voluntary Extension of Lock-up Agreements with Company Insiders

3 years ago

News in SummaryCloud DX insiders (as defined by the TSX Venture Exchange) holding approximately 33% of the issued and outstanding…

CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry

3 years ago

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 17, 2022 / CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company developing…

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

3 years ago

IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film, microneedle patch and biosynthesis…